Nimbleheart

NimbleHeart is a medical device company specializing in wearable cardiac monitoring technology. The company has developed an FDA 510(k) cleared exercise ECG telemetry system that uses patented dry electrode technology, eliminating the need for traditional adhesive electrodes and skin preparation during cardiac stress testing and rehabilitation.

The company's technology enables remote cardiac screening and monitoring through a harness-based wearable device. Founded by Sonal Tambe (CEO with 15+ years in product development at Apple, Marvell Semiconductors, and St. Jude Medical) and Dr. Pramod Deshmukh (Electrophysiologist with 20+ years in cardiovascular disease), NimbleHeart combines hardware engineering, clinical expertise, and signal processing capabilities. The team includes advisors from Stanford, Beaumont Hospital, and Oregon State University.

NimbleHeart's partnerships include NASA Exploration Medical Capabilities, Franciscan Health, and major cardiac rehabilitation associations. The company launched preventive cardiac screening services for at-risk individuals in September 2024 and expanded remote cardiac screening offerings in February 2025.

Consider NimbleHeart when seeking an alternative to traditional exercise ECG monitoring that prioritizes patient comfort and eliminates adhesive electrode challenges. The technology is particularly well-suited for patients with skin sensitivities, excessive body hair, or those requiring frequent cardiac monitoring where traditional electrodes become impractical.

Organizations should expect a device-as-a-service model with remote monitoring capabilities, clinical follow-up support, and comprehensive reporting. Best fits scenarios where improving patient experience in cardiac rehabilitation or stress testing is a priority, particularly for programs serving diverse patient populations or those emphasizing preventive cardiac care.

NimbleHeart operates exclusively in the cardiac care vertical, with FDA 510(k) clearance for medical device use in clinical settings. The company specifically serves cardiac rehabilitation programs, preventive cardiology services, and organizations conducting cardiac stress testing. Their partnerships with the American Association of Cardiovascular and Pulmonary Rehab and California Society of Cardiac Rehabilitation demonstrate deep integration within the cardiac care community. The technology addresses HIPAA-relevant remote monitoring needs while focusing on improving clinical workflows in cardiac assessment.

Cardiac rehabilitation centers and health systems with established cardiology programs seeking to enhance patient experience and compliance. Organizations serving patient populations with skin sensitivities, those requiring frequent monitoring, or programs focused on preventive cardiac screening. Best matched with buyers who value clinical innovation and are willing to adopt newer technologies with strong clinical advisory backing.